Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Federal Trade Commission
US Department of Justice
Cipla
Harvard Business School
AstraZeneca
Fuji
Farmers Insurance
Merck

Generated: January 16, 2019

DrugPatentWatch Database Preview

Formulation information for generic ingredient: degarelix acetate

« Back to Dashboard

Degarelix

CASRN: 214766-78-6UNII:

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Cantor Fitzgerald
Mallinckrodt
Teva
Julphar
McKinsey
Fuji
Colorcon
Fish and Richardson